Seroba Life Sciences

Seroba Life Sciences Seroba Life Sciences is a European life sciences VC headquartered in Dublin, with Fund IV closed at €123M in February 2024. The fund targets up to 12 investments per vintage, with 5 already made including Perfuze, Sibylla Biotech, Deciphex, Complement Therapeutics, and Artica. The latest investment is Azafaros' Series B in May 2025, bringing total investments to 50. The LP base reads like a who's who of European development finance: EIF, Ireland Strategic Investment Fund (IS